Half of People Stop GLP-1s Within a Year — Here's How to Be the Other Half

You Are Not Doomed to Be a Statistic

The data is real: roughly half of people who start GLP-1 medications stop within the first year. But here is what the statistic does not tell you — every one of those drop-offs has a specific, addressable cause. Understanding them is the difference between being in the half that quits and the half that stays.

Reason 1: Cost

The number-one driver. Insurance changes, job transitions, or flat-out unaffordable prices force people to stop. The fix: The landscape changed in 2026. Oral pills start at $149/month. Compounded injectables from $99/month. Medicare covers GLP-1s starting July 1. Before cost forces you to stop, talk to your provider about switching to a more affordable option.

Reason 2: Side Effects

Nausea and GI discomfort are worst during the first 2-3 months. Some people give up before reaching the therapeutic dose. The fix: Ask about slower titration, dietary adjustments, or switching formulations. Many side effects improve with time. The first months are the hardest — but they get better.

Reason 3: Unmet Expectations

Social media sets unrealistic timelines. Clinical reality: 15-20% loss over 12-18 months. That is 1-2 pounds per week at best, with plateaus. The fix: Measure success by health metrics (A1C, blood pressure, energy) — not just the scale.

Reason 4: Fear of Forever

Some people view GLP-1s as a jumpstart, not long-term treatment. The fix: Obesity is chronic, like blood pressure or diabetes. Talk to your provider about what maintenance looks like — it may be a lower dose or an oral option that feels more sustainable.

Reason 5: Injection Fatigue

The weekly routine gets old. The fix: You can now switch to a daily pill (Wegovy pill or orforglipron) without losing your progress. The ATTAIN-MAINTAIN trial specifically proved this works.